Quality of life in gastroenterology: conception and research policy (a review)
- Authors: Novik AA1, Ionova TL1, Denisov NL1
-
Affiliations:
- Issue: Vol 78, No 10 (2003)
- Pages: 42-45
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/29662
- ID: 29662
Cite item
Full Text
Abstract
References
- Spiker В. Quality of life and pharmacoeconomics in clinical trials. 2"d ed. Philadelphia; New York: Lippincott-Raven; 1996. 24.
- Новик А. А., Ионова Т. И., Кайнд П. Концепция исследования качества жизни в медицине. СПб: Элби; 1999.
- Guilemin F, Bombardier С, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J. Clin. Epidemiol. 1993; 46 (12): 1417-1432.
- Dimenas E., Gtise H., Hallerback B. et al. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand. J. Gastroenterol. L995; 30(11): 1046-1052.
- Glise H., Hallerback В., Wikiund I. Quality of life: a reflection of symptoms and concerns. Ibid. 1996; suppl. 221: 14-17.
- Revicki D. A., Wood M., Wikiund I., Crawley J. Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease. Quality Life Res. 1998; 7: 75-83.
- Revicki D. A., Wood M., Maton P. N., Sorensen S. The impact of gastroesophageal reflux disease on health-related quality oflife. Am. J. Med. 1998; 104: 252-258.
- Talley N. J., Vakil H., Ballard E. D., Fennerty M. B. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N. Engl. J. Med. 1999; 341 (15): 1106- 1111.
- Wilhelmsen I., Haug Т. Т., Ursin H., Berstad A. Discriminant analysis of factors distinguishing patients with functional dyspepsia from patients with duodenal ulcer. Significance of somatization. Dig. Dis. Sci. 1995; 40 (5): 1105-1111.
- Drossman D. A., Li Z., Leserman J., Patrick D. Ulcerative colitis and Crohn's disease health status scale for research and clinical practice. J. Clin. Gastroenterol. 1992; 15: 104-112.
- Frampton J. E., McTavish D. Ranitidine: a pharmacoeconomic evaluation of its use in acid-related disorders. Pharmacoeco nomics 1994; 6 (1): 57-89.
- Wikiund I., Bardhan K. D., Muller-Lissner S. et al. Quality of life during acute and intermittent treatment of gastroesophageal reflux disease with omeprazol compared with ranitidine. Results from a multicentre clinical trial. The European Study Group. Ital. J. Gastroenterol Hepatol. 1998; 30 (1): 19-27.
- Lundell L., Blomkvist A., Wikiund I. Quality of life assessment after laparoscopic fundoplication: results of prospective clinical study. Scand. J. Gastroenterol. 1996; 31 (suppl. 221): 1 - 25.
- Thirlby R. C, Land J. S., Fenster L. F, Lonborg R. Effect of surgery on health-related quality of life in patients with infla matory bowel disease: a prospective study. Arch. Surg. 1998; 133 (8): 826-832.
- Sagar P., Lewis W., Holdsworth P. J. et al. Quality of life after restorative proctocolectomy with a pelvic ideal reservoir compares favourably with that of patients with medically treated colitis. Dis. Colon Rect. 1993; 35: 584-592.
- Lewin T. R. A cost analysis of HP eradication strategies in a large health maintenance organisation. Am. J. Gastroenterol. 1998; 93 (5): 743-747.
- Phull P. S., Ryder S. D., Halliday D. et al. The economic and quality-of-life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease - a community-based study. Postgrad. Med. J. 1995; 71 (837): 413-418.
- Prach А. Т., Malek M., Tavakoli M. et al. H2-antagonist maintenance therapy versus Helicobacter pylori eradication in patients with chronic duodenal ulcer disease: a prospective study. Aliment. Pharmacol. Ther. 1998; 12 (9): 873-880.
- Velanovich V. Long-term quality of life outcome after treatment for Helicobacter pylori gastric infection. Am. Surg. 1997; 63 (6): 551-554.
- Wilhelmsen I. Quality of life and Helicobacter pylori eradication. Scand. J. Gastroenterol. 1996; 31 (suppl. 221): 18-20.
- Hallert C, Granno C, Grant С et al. Quality of life of adult coeliac patients treated for 10 years. Ibid. 1998; 33: 933-938.